Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-choline PET-MRI in Carotid Artery Atherosclerosis
NCT02640313Phase 3Unknown
- Sponsor
- Maastricht University Medical Center+
- Start
- Dec 2015
- Primary completion
- Mar 2024
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
Phase 3, open-label trial of fluorine-18 fluorocholine in Carotid artery disease (CAD), sponsored by Maastricht University Medical Center+. Primary endpoints: 18F-choline uptake at 1 year and Correlation of 18F-choline uptake with CD68-positivity at 1 year. Status: unknown.
02
Drugs
fluorine-18 fluorocholine
03
Conditions
Carotid artery disease (CAD)
Beyond the preview
Go deeper on NCT02640313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02640313.